HXBM (Helix Biomedix) Research & Development: $0.38 Mil (TTM As of Sep. 2012)


What is Helix Biomedix Research & Development?

Helix Biomedix HXBM Research & Development is $0.38 Mil as of Sep. 2012.

Research & Development is the aggregate amount of research and development expenses during the year. Helix Biomedix's Research & Development for the three months ended in Sep. 2012 was $0.13 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2012 was $0.38 Mil.

Helix Biomedix  (OTCPK:HXBM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Helix Biomedix Research & Development Related Terms

Helix Biomedix Research & Development Historical Data

* Premium members only.

The historical data trend for Helix Biomedix's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helix Biomedix Research & Development Chart

Helix Biomedix Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.83 0.72 0.75 0.50

Helix Biomedix Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.08 0.09 0.09 0.13

Helix Biomedix Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.38 Mil mean?
Helix Biomedix (HXBM) has a Research & Development of $0.38 Mil as of Sep. 2012. Research and development expense is the total cost for research and development activities. View historical data on Helix Biomedix and its competitors.
Is Helix Biomedix's Research & Development too high?
Helix Biomedix's current Research & Development is $0.38 Mil.
How does Helix Biomedix's Research & Development compare to XBIO and CBLI?
Helix Biomedix's Research & Development of $0.38 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Helix Biomedix and its competitors. Helix Biomedix's current Research & Development is $0.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helix Biomedix stock overvalued right now?
Helix Biomedix (HXBM) has a current Research & Development of $0.38 Mil. The current Research & Development is $0.38 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Helix Biomedix (HXBM), the current Research & Development is $0.38 Mil as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Helix Biomedix Business Description

Address 19125 North Creek Parkway, Suite 120, Bothell, WA, USA, 98011
Helix Biomedix Inc is a Delaware-based biopharmaceutical company that focuses on the early-stage development of peptide-based therapeutics for dermatology and skin health. The Company is in the preclinical stage, advancing a rare disease drug program for xeroderma pigmentosum, and plans to seek orphan drug designation before entering clinical development. Leveraging its proprietary peptide technology, Helix BioMedix aims to address unmet needs in rare dermatological conditions and has a history of developing patented bioactive peptides for topical personal care use.